Yi Zhao

Dr. Yi Zhao


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PDF file
YZYi Zhao
Yi Zhao
CZCheng-Feng Zhang
Cheng-Feng Zhang
HRHeidemarie Rossiter
Heidemarie Rossiter
LELeopold Eckhart
Leopold Eckhart
UKUlrich König
Ulrich König
FGFlorian Gruber
Florian Gruber

26 May 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YZYi Zhao
Yi Zhao
PTPing Tu
Ping Tu
GZGuoyu Zhou
Guoyu Zhou
ZZZhanchao Zhou
Zhanchao Zhou
XLXiaoxi Lin
Xiaoxi Lin
XZXuejun Zhu
Xuejun Zhu
Photodynamic therapy (PDT) has shown potentially beneficial results in treating port-wine stain, but its benefit–risk profile remains undefined. This study aimed to evaluate the efficacy and safety of PDT conducted with hemoporfin and a 532 nm continuous wave laser to treat port-wine stain clinically. This randomized clinical trial was conducted in eight hospitals in China. Participants were adolescent and adult patients (age range: 14–65 years old) with port-wine stain. During stage 1 (day 1 to week 8) all patients were randomized at a 3:1 ratio to treatment (532 nm laser irradiation (96–120 J/cm2) with hemoporfin (5mg/kg; PDT-hemoporfin, n = 330)) or placebo groups (irradiation with placebo (PDT-placebo, n = 110)); during stage 2 (week 8 to 16) patients in both groups were offered treatment. Clinician-evaluators, who were blind to the study, classified each case on the following four-level scale according to assessment of before and after standardized pictures of the lesion area: no improvement: <20%; some improvement: 20–59%; great improvement: 60–89%; or nearly completely resolved: ≥90%. The primary efficacy endpoint was proportion of patients achieving at least some improvement at week 8. The secondary efficacy endpoints were proportion of patients achieving nearly completely resolved or at least great improvement at week 8, proportion of patients achieving early completely resolved, at least great improvement, or at least some improvement at week 16, and the corresponding satisfaction of the investigators and the patients (designated as ‘excellent’, ‘good’, ‘moderate’, or ‘ineffective’) at weeks 8 and 16. Compared to the PDT-placebo group, the PDT-hemoporfin group showed a significantly higher proportion of patients that achieved at least some improvement (89.7% [n = 295; 95% CI, 85.9%-92.5%] vs. 24.5% [n = 27; 95% CI, 17.4%-33.3%]) at week 8 (P < 0.0001) and higher improvements for all secondary efficacy endpoints. Treatment reactions occurred in 99.5% (n = 731; 95% CI, 98.7%-99.8%) of the PDT-hemoporfin treatments (n = 735). Hyperpigmentation occurred in 22.9 per 100 patient-treatments (n = 168; 95% CI, 20.0–26.0) in the PDT-hemoporfin treated patients. Hemoporfin-mediated PDT is an effective and safe treatment option for adolescent and adult patients with port-wine stain. Chinese Clinical Trial Registry ChiCTR-TRC-08000213

4 January 2011 in Photodermatology, Photoimmunology & Photomedicine
Verified
Journal Article
Closed access
PDF file
YZYi Zhao
Yi Zhao
ZZZhanchao Zhou
Zhanchao Zhou
GZGuoyu Zhou
Guoyu Zhou
PTPing Tu
Ping Tu
QZQingshan Zheng
Qingshan Zheng
XZXuejun Zhu
Xuejun Zhu

9 May 2018 in The Journal of Dermatology
Verified
Journal Article
Open access
PDF file
SIShinichi Imafuku
Shinichi Imafuku
MZMin Zheng
Min Zheng
YTYayoi Tada
Yayoi Tada
XZXibao Zhang
Xibao Zhang
CTColin Theng
Colin Theng
HSHae Jun Song
Hae Jun Song
A working group of dermatologists in Asian countries assessed the current status of psoriatic management in the region to prepare a consensus report on topical treatment in mild to moderate plaque psoriasis. Even though the association of psoriasis with systemic comorbidities is increasingly acknowledged, psoriasis is still lower in health‐care priority lists in the region. The psychosocial impact of psoriasis may be greater in Asian countries due to cultural norms and social discrimination. Non‐adherence to treatment is also common among Asians. The current care given to patients with mild to moderate psoriasis needs to be streamlined, enhanced and organized with a patient‐centered care approach to achieve better outcomes. A comprehensive assessment of the disease severity and its impact on a patient's life is required before initiating treatment. Education and active involvement of the patient in the treatment plan is an important part of psoriatic management. It is recommended to personalize topical treatment to meet the needs of the patient, depending on disease severity, psychosocial impact, the patient's expectations and, more importantly, the patient's willingness and ability to actively follow the treatment procedure. Fixed‐dose combination of corticosteroid and vitamin D analogs is the preferred topical medication for both initial and maintenance phases of treatment. The fast containment of the disease is the goal of the initial phase of 4–8 weeks and it demands a potent fast‐acting topical therapy. Satisfactory control of the disease and prevention of relapses should be achieved during the maintenance phase with twice a week or weekend applications.

24 January 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DCDian Chen
Dian Chen
HTHsiaoHan Tuan
HsiaoHan Tuan
EZEray Yihui Zhou
Eray Yihui Zhou
DLDeHua Liu
DeHua Liu
YZYi Zhao
Yi Zhao
Vitiligo is an acquired depigmented skin disease resulting in white macules, which may significantly impair the quality of life (QoL) of the patients. To estimate the QoL in Chinese vitiligo patients using camouflage with a more detailed description, and to identify the possible risk factors related to poor QoL. An online survey was conducted in vitiligo patients using camouflage from a vitiligo community. Survey questions included demographic, clinical information, dermatology- and vitiligo-specific QoL questionnaires. Multivariate logistic analysis was performed to identify risk factors that related to poor QoL. In total, 884 respondents were included in the analyses, of which 413 (46.7%) were male. The score of DLQI was 5.83±5.75 (mean± SD). Age, gender, marriage status, occupational status, anogenital involvement, patient-perceived severity (presented by VAS score), symptoms as itching, pain, sunburn and koebner phenomenon, total cost of treatment and degree of satisfaction in camouflage therapy were independently associated with DLQI score (p<0.05). Vitiligo has considerable impact on QoL of affected patients in Chinese population even when they were using camouflage. Camouflage might be helpful to improve QoL of the patients.

21 October 2021 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
QFQiuyue Fu
Qiuyue Fu
YZYanjiao Zhang
Yanjiao Zhang
peng wangpeng wang
peng wang
Jiang PiJiang Pi
Jiang Pi
XQXun Qiu
Xun Qiu
JXJun-Fa Xu
Jun-Fa Xu